IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners L.P.

Q1 2018 Holdings

Filed 2018-04-25 | 4 holdings | $162.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Apellis Pharmaceuticals, IncCOM037530106$79.1K3,579,30548.8%
Menlo Therapeutics Inc.COM586858102$54.9K1,461,55233.9%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$17.5K875,00010.8%
Nabriva Therapeutics PLCSHSG63637105$10.7K2,122,9626.6%